Dr. Richard Rozek
Total Page：16
File Type：pdf, Size：1020Kb
Dear Ms. Overstreet: I am interested in being considered for the vacancy on the Glynn Brunswick Memorial Hospital Authority. Per the instructions with the vacancy announcement, I attached a copy of my vita to the letter. I am an economist with a specialty in health care economics. I have worked on competition, regulation, contract, and tax issues in health care during my career in academic, federal government, and private sector positions. I have written articles on health care issues and testified in major health care litigations. I have owned a home on Jekyll Island since 1993. Please let me know if you need additional information. Sincerely, Richard P. Rozek, Ph.D. RICHARD P. ROZEK, PH.D. CONTACT INFORMATION Redacted Jekyll Island, GA 31527 Phone: 912 Redacted Redacted gmail.com BACKGROUND Dr. Rozek received a B.A. degree in Mathematics with honors from the College of St. Thomas, a M.A. degree in Mathematics from the University of Minnesota, and M.A. and Ph.D. degrees in Economics from the University of Iowa. Dr. Rozek began his professional career as an Assistant Professor at the University of Pittsburgh where he taught courses in industrial organization, mathematical economics, and microeconomic theory. Dr. Rozek then worked for over six years in the Bureau of Economics at the Federal Trade Commission in a series of senior staff positions including Deputy Assistant Director for Antitrust. While at the FTC, Dr. Rozek evaluated antitrust and regulatory issues in electric and gas utilities, oil pipelines, soft drinks, for-profit and nonprofit hospitals, motion pictures, pharmaceuticals, and information industries. For two years, Dr. Rozek worked as the economist at the Pharmaceutical Manufacturers Association (now PhRMA). He conducted research on issues such as the cost to develop a new pharmaceutical, pharmaceutical industry profitability, benefits and costs of intellectual property protection, productivity of R&D personnel in the pharmaceutical industry, and reform of the health care reimbursement system. Since 1987, Dr. Rozek has worked on projects in the antitrust/health, intellectual property, energy, and telecommunications practices at NERA Economic Consulting. Dr. Rozek has participated in the design of bidding processes for power generation markets and analysis of hospital rate regulation schemes. He has addressed economic issues in industries such as agricultural chemicals, automobiles, cellular telephone service, convenience food, electric equipment, electric utilities, hospitals, medical devices, newspapers, pharmaceuticals, and professional services. He has worked for plaintiffs and defendants in antitrust, contract dispute, patent infringement, personal injury, and libel cases. Dr. Rozek has authored public policy studies and valued intangible and tangible property for tax and other business purposes. Dr. Rozek's articles have appeared in Applied Economics, Contemporary Policy Issues, Energy Journal, Economics Letters, Journal of Economics, Journal of World Intellectual Property, Mathematical Modelling, Metroeconomica, Research Policy, and Tax Notes International. He has been a referee for several professional journals and is a member of the American Economic Association and the National Association for Business Economics. - 2 - RICHARD P. ROZEK EDUCATION UNIVERSITY OF IOWA Ph.D., Economics, 1976 M.A., Economics, 1974 UNIVERSITY OF MINNESOTA M.A., Mathematics, 1971 COLLEGE OF ST. THOMAS B.A., Mathematics, 1969 (cum laude) EMPLOYMENT NERA ECONOMIC CONSULTING, Washington, DC 2012- Special Consultant 2000-2012 Senior Vice President 1991-2000 Vice President 1987-1991 Senior Consultant Worked on projects involving regulated industries including design of bidding processes for acquiring power and allocating spectrum, and analysis of hospital rate regulation schemes; competition analyses in industries such as convenience food, electric equipment, electric utilities, hospitals, newspapers, pharmaceuticals, telecommunications and professional services; damage estimates in antitrust, contract dispute, patent infringement, personal injury and libel cases; compensation issues in professional sports; public policy studies in the pharmaceutical industry (intellectual property protection, parallel trade and pricing); and transfer pricing studies for consumer product, pharmaceutical and medical device firms. PHARMACEUTICAL MANUFACTURERS ASSOCIATION, Washington, DC 1985-1987 Senior Analyst, Economics Analyzed issues affecting the research based pharmaceutical industry including intellectual property protection, costs and benefits of pharmaceutical therapies, the cost to develop a new pharmaceutical product, industry profitability and Medicare/Medicaid reform. FEDERAL TRADE COMMISSION, Washington, DC 1979-1985 Staff Economist, Antitrust and Regulatory Analysis Divisions, Bureau of Economics Analyzed antitrust and regulatory issues involving computers, hospitals, oil pipelines, electric utilities, securities (stock and futures), soft drinks, and various consumer goods industries. - 3 - RICHARD P. ROZEK 1982-1983 Deputy Assistant Director for Antitrust, Division of Antitrust, Bureau of Economics Supervised eight staff economists working on various antitrust matters. UNIVERSITY OF PITTSBURGH, Pittsburgh, PA 1976-1979 Assistant Professor, Department of Economics Taught graduate and undergraduate courses in general equilibrium theory, mathematical economics, mathematics for economists, industrial organization, operations research and microeconomic theory; served on departmental committees; and supervised graduate student research projects. UNIVERSITY OF IOWA, Iowa City, IA 1973-1976 Research Assistant, Teaching Assistant, Instructor, College of Business Administration ST. MARY’S COLLEGE, Winona, MN 1972-1973 Instructor, Department of Mathematics Taught undergraduate courses in number theory, integral and differential calculus, probability and statistics. UNIVERSITY OF MINNESOTA, Minneapolis, MN 1969-1972 Teaching Assistant, School of Mathematics PUBLICATIONS “An Economic Perspective on Small and Large Molecule Pharmaceutical Technologies,” forthcoming in Biotechnology Patenting: Three Decades since Diamond v. Chakrabarty (J. Kesan and G. Myles, editors), New York: Oxford University Press, 2013. Spanish version is available on the Cediquifa website. “Switching Pharmaceutical Products from Prescription to Over-the-Counter: The Debate in the U.S.,” European Journal of Risk Regulation, Volume 3, Issue 4, 2012, pp. 601-607. “Economics as a Guide to Developing Public Policies for Biosimilar Pharmaceutical Products,” Queen Mary Journal of Intellectual Property, Volume 2, Number 4, 2012, pp. 363-375. “Risk and Regulatory Factors Affecting Location Decisions by Research-Based Pharmaceutical Companies,” European Journal of Risk Regulation, Volume 2, Issue 1, 2011, pp. 92-103. "Patent Wars and Authorised Generics in the USA: Assessing the Issues" (with J. Lowe and E. Radel), Healthy IPRs: A Forward Look at Pharmaceutical Intellectual Property (M. Pugatch and A. Jensen, editors), London: The Stockholm Network, 2007. - 4 - RICHARD P. ROZEK “Encouraging Cooperation Among the Academic, Government, and Private Sectors in U.S. Biomedical R&D” (with B. Dickensheets), The Intellectual Property Debate: Perspectives from Law, Economics, and Political Economy (M.P. Pugatch, editor), Northampton: Edward Elgar Publishing, Inc., 2006. “What Is an Idea Worth?” (with G. Korenko), The Intellectual Property Debate: Perspectives from Law, Economics, and Political Economy (M.P. Pugatch, editor), Northampton: Edward Elgar Publishing, Inc., 2006. “A Market-Based Approach for Tangible Property Transfer Pricing” (with E. Bishko and G. Korenko), Transfer Pricing Report, Volume 13, March 16, 2005, pp. 1110-1115. “Using In-Country Comparables to Measure the Returns Due Pharmaceutical Marketing and Distribution Affiliates” (with G. Korenko), International Transfer Pricing Journal, Volume 10, November/December 2003, pp. 211-217. “Investment Incentives Created by the Montreal Protocol and FDA Policy on Albuterol” (with E. Bishko), Journal of World Intellectual Property, Volume 6, November 2003, pp. 807-825. “Broad-Based Compulsory Licensing of Pharmaceutical Technologies: Unsound Public Policy” (with R. Rainey), Journal of World Intellectual Property, Volume 4, July 2001, pp. 463-480. “TRIPs Ruling and the Developing Countries: Prospects after Seattle,” Journal of World Intellectual Property, Volume 4, March 2001, pp. 271-275. “Valuing Intellectual Property Assets for Licensing,” The Law and Business of Licensing: Licensing in the 21st Century (B.I. Friedlander and L.W. Evans, editors), West Group, 2000, pp. 345-362. “The Effects of Compulsory Licensing on Innovation and Access to Health Care,” Journal of World Intellectual Property, Volume 3, November 2000, pp. 889-917. “Transfer Prices for the Intangible Property Embodied in Products with Extraordinary Profit Potentials” (with G. Korenko), Tax Notes International, Volume 19, October 18, 1999, pp. 1553-1565. “The Costs to the U.S. Health Care System of Extending Marketing Exclusivity for Taxol®” (with R. Berkowitz), Journal of Research in Pharmaceutical Economics, Volume 9, September 1999, pp. 21-41. “The TRIPs Agreement and Access to Health Care” (with N. Tully), Journal of World Intellectual Property, Volume 2, September 1999, pp. 813-819. - 5 - RICHARD P. ROZEK “Regulatory Influences on the Decision to Introduce Pharmaceutical Products in Japan” (with T. Nambu and R. Rapp), Journal of World Intellectual Property,